
Gloria Pharmaceuticals
closedHarbin Gloria Pharmaceuticals is engages in the research, development, production, and sale of pharmaceutical products.
Market cap
$880m
Enterprise value
$807m
Share price
CNY2.91 002437.SZ
Recent deals
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | 000k |
No items found
No investors found
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (40 %) | 3 % | (1 %) | (16 %) | (7 %) | 4 % | 11 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 31 % | 10 % | 1 % | 13 % | 16 % | 15 % | 15 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 13 % | 1 % | (9 %) | 5 % | 10 % | 9 % | 10 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 4 % | 3 % | 3 % | 3 % | 4 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Otsuka Pharmaceutical Dec 2020